Projects

Our research is supported by a number of national and international funding bodies:

  • European Comission 6th Framework Programme;
  • Dirección General de Investigación y Tecnología (DGICYT), Comisión Interministerial de Ciencia y Tecnología (CICYT), Dirección General de Educación Superior (DGES) and Instituto de Salud Carlos III, Governmet of Spain;
  • Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR), Government of Catalunya;
  • Interuniversity Attraction Poles (IAP) Programme, Government of Belgium;
  • Fundació La Marató de TV3

Funded by

Project

Name

Start

Date

End

Date

MICIU

PID2019-109240RB-I00

Modulation of G protein coupled receptor heteromers by ligands and proteins (ModGPCRHet)

01-Ene-2020

31-Dic-2022

MICIU

PCI2019-103720

Fighting antibiotic-resistant superbugs with anti-persister compounds targeting the stringent response

01-Ene-2019

31-Dic-2021

MINECO

SAF2015-74627-JIN

Targeting GPCR heteromers

01-Ene-2017

31-Dic-2019

MINECO

SAF2016-77830-R

Modulation of GPCRs by ligands and partner proteins

30-Dic-2016

29-Dic-2019

European Commission

FP7-HEALTH-F5-2013-603160

Advances in Small Trials dEsign for Regulatory Innovation and eXcellence (ASTERIX)

01-Oct-2014

01-Sept-2017

MINECO

SAF2013-48271-C2-2-R

New targets and therapeutic strategies

01-Ene-2014

31-Dic-2016

MICINN

UNAB10-4E-133

A network of computers for intensive calculation

01-Oct-2011

01-Oct-2013

MICINN

SAF2010-22198-C02-02

Computational Methods in Drug Design. New approaches for GPCR modulation

01-Oct-2010

01-Oct-2013

AGAUR

2009SGR550

Research group of Generalitat Catalunya

01-Jan-2009

31-Dec-2013

ISCIII

RD07/0067/0008

Network of computational biomedicine (COMBIOMED)

01-Jan-2008

31-Dec-2011

Belgian Fed. Off.

IAP-network P6/14

G protein-coupled receptors, from structure to disease

01-Jan-2007

31-Dec-2011

CICYT

SAF2007-67008

Development of new methodologies of molecular design for drug discovery and integration of new techniques for the identification and validation of therapheutic targets

01-Oct-2007

01-Oct-2010

CICYT

SAF2006-04966

Molecular mechanisms of agonist-induced activation of G protein coupled receptors

01-Oct-2006

30-Sep-2009

AGAUR

SGR2005-00390

Research Group of Generalitat de Catalunya

1-Jan-2005

31-Dec-2008

CICYT

SAF2004-07103

Design, synthesis and development of new therapeutic compounds targeting cellular mechanisms of transmembrane (the serotonin and cannabinoid GPCRs) and intracellular (the SH2 domain of Grb2) signaling

13-Dec-2004

13-Dec-2007

European Commission

LSHB-CT-2003-503337

Functional Pharmacogenomics of G Protein-Coupled Receptor

01-Jan-2004

31-Dec-2006

CICYT

SAF2002-01509

Bioinformatic approaches leading to an understanding of the structure and activity of G protein-coupled receptors

01-Dec-2002

01-Dec-2005

Belgian Fed. Off.

IAP-network P5/30

G protein-coupled receptors: functional genomics, molecular pharmacology, structure-function studies

01-Jan-2002

21-Dec-2006

DGES

PB98-0907

Analysis of structural and energetic factors of minor groove-intercalating DNA-bending proteins

30-Dec-1999

30-Dec-2002

CICYT

SAF99-0073

Modeling and simulation of the process of G protein-mediated transmembrane signal transduction

01-Jun-1999

01-Jun-2002

Fundació La Marató de TV3

1014/97

Computer–assisted design of agonists and antagonists selective to the muscarinic receptors as a treatment of the Alzheimer’s disease

01-Jan-1998

21-Dec-2000

DGICYT

PB95-0624

Modeling and simulation of the process of G protein-mediated transmembrane signal transduction

01-Nov-1996

01-Nov-1999

DGICYT

PB92-0623

Modeling and simulation of the structure and activity of membrane receptors

31-Jun-1993

31-Dec-1996